|
Index of reports
> Cases with Disease Progression ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include disease progression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in
Reported by a consumer/non-health professional from Canada on 2012-07-30
Patient:
Reactions: Disease Progression
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Epirubicin
Indication: Product Used FOR Unknown Indication
Fluorouracil
Indication: Product Used FOR Unknown Indication
Xeloda
Indication: Product Used FOR Unknown Indication
Possible Epirubicin side effects in male
Reported by a physician from Poland on 2012-07-24
Patient: male, weighing 77.0 kg (169.4 pounds)
Reactions: Dyspnoea, Pleural Effusion, Palmar-Plantar Erythrodysaesthesia Syndrome, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Capecitabine
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Epirubicin
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Oxaliplatin
Indication: Metastatic Gastric Cancer
Start date: 2010-10-27
End date: 2011-04-06
Possible Epirubicin side effects in 63 year old male
Reported by a physician from Poland on 2012-06-27
Patient: 63 year old male
Reactions: Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Pleural Effusion, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Capecitabine
Indication: Product Used FOR Unknown Indication
Epirubicin
Indication: Product Used FOR Unknown Indication
Oxaliplatin
Indication: Product Used FOR Unknown Indication
Possible Epirubicin side effects in 54 year old female
Reported by a physician from Japan on 2011-11-03
Patient: 54 year old female
Reactions: Renal Disorder, Liver Disorder, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Epirubicin
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Gemcitabine
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Herceptin
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Other drugs received by patient: Paclitaxel; Gemcitabine; Lapatinib Tosilate; Xeloda; Docetaxel
|
